Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Mon, 10/28/13 - 12:10 pm
Bristol-Myers Squibb
nivolumab
lung cancer
Time Is No Friend To Synta's Lung Cancer Drug
TheStreet.com
Mon, 10/28/13 - 09:52 am
Synta Pharmaceuticals
lung cancer
ganetespib
Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganetespib in NSCLC at the 2013 World Conference on Lung Cancer
Yahoo/BusinessWire
Sat, 10/26/13 - 11:12 am
ganetespib
lung cancer
Synta Pharmaceuticals
adenocarcinoma
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
non-small cell lung cancer
Merck drug triggers response in 24 pct of lung cancer patients
Yahoo/Reuters
Tue, 10/1/13 - 06:04 pm
Merck
MK-3475
lung cancer
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Fierce Biotech
Mon, 09/30/13 - 05:00 pm
Roche
PD-L1
non-small cell lung cancer
MPDL3280A
lung cancer
Roche immunotherapy drug may be "game changer" in lung cancer
Yahoo/Reuters
Sun, 09/29/13 - 01:50 pm
Roche
lung cancer
MPDL3280A
Synta Announces Presentation of Ganetespib Results at the 2013 European Cancer Congress
Yahoo/BusinessWire
Sat, 09/28/13 - 12:14 pm
Synta Pharmaceuticals
lung cancer
ganetespib
ArQule up on hope for lung cancer drug revival
Reuters
Fri, 09/27/13 - 11:51 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
Motley Fool
Sun, 09/22/13 - 11:23 am
LDK378
Novartis
bavituximab
Peregrine Pharmaceuticals
nivolumab
Bristol-Myers Squibb
lambrolizumab
Merck
lung cancer
CO-1686
Clovis Oncology
Is This Experimental Lung Cancer Drug Back on Track?
Motley Fool
Tue, 09/10/13 - 11:55 am
lung cancer
Peregrine Pharmaceuticals
bavituximab
Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
Reuters
Mon, 09/9/13 - 10:47 am
lung cancer
Oncolytics
Reolysin
Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014
Reuters
Wed, 09/4/13 - 05:37 pm
Eli Lilly
Alimta
lung cancer
patents
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Seeking Alpha
Sat, 08/31/13 - 11:20 am
Eli Lilly
necitumumab
lung cancer
Is This New Lung Cancer Treatment a Game Changer?
Motley Fool
Sat, 08/17/13 - 11:23 am
Eli Lilly
lung cancer
necitumumab
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wed, 08/14/13 - 09:13 am
lung cancer
Eli Lilly
necitumumab
non-small cell lung cancer
Eli Lilly Lung Cancer Drug Raises Patient Survival in Trial
Bloomberg
Tue, 08/13/13 - 10:48 am
necitumumab
Eli Lilly
lung cancer
Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Yahoo/AP
Thu, 06/27/13 - 11:14 am
Peregrine Pharmaceuticals
lung cancer
bavituximab
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Thu, 06/27/13 - 10:37 am
Seattle Genetics
antibody-drug conjugate
Astellas
ASG-15ME
Agensys
bladder cancer
lung cancer
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »